XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

REVENUE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Type and by U.S versus Rest of World | The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):
| Three months ended June 30,
| 2024 |  |  | 2023
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Testing revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 80.9 |  |  | $ | 10.6 |  |  | $ | 91.5 |  |  |  | $ | 64.5 |  |  | $ | 12.2 |  |  | $ | 76.7 |
Tumor Profiling | 26.7 |  |  | 5.9 |  |  | 32.6 |  |  |  | 27.3 |  |  | 8.7 |  |  | 36.0 |
Prenatal | 44.2 |  |  | 0.2 |  |  | 44.4 |  |  |  | 35.4 |  |  | 0.2 |  |  | 35.6 |
Pharmacogenomics | 43.0 |  |  | — |  |  | 43.0 |  |  |  | 35.2 |  |  | — |  |  | 35.2 |
Total revenue | $ | 194.8 |  |  | $ | 16.7 |  |  | $ | 211.5 |  |  |  | $ | 162.4 |  |  | $ | 21.1 |  |  | $ | 183.5 |
| Six months ended June 30,
| 2024 |  |  | 2023
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Testing revenues: |  |  |  |  |  |  |  |  |  |  |  |
Hereditary Cancer | $ | 157.2 |  |  | $ | 22.4 |  |  | $ | 179.6 |  |  |  | $ | 128.5 |  |  | $ | 23.9 |  |  | $ | 152.4 |
Tumor Profiling | 50.6 |  |  | 12.9 |  |  | 63.5 |  |  |  | 56.1 |  |  | 17.2 |  |  | 73.3 |
Prenatal | 88.3 |  |  | 0.4 |  |  | 88.7 |  |  |  | 71.4 |  |  | 0.4 |  |  | 71.8 |
Pharmacogenomics | 81.9 |  |  | — |  |  | 81.9 |  |  |  | 67.2 |  |  | — |  |  | 67.2 |
Total revenue | $ | 378.0 |  |  | $ | 35.7 |  |  | $ | 413.7 |  |  |  | $ | 323.2 |  |  | $ | 41.5 |  |  | $ | 364.7 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration